Research Article

Prognostic Factors Predicting Poor Outcome in Cancer Patients with Febrile Neutropenia in the Emergency Department: Usefulness of qSOFA

Table 2

Comparison of vital signs and laboratory findings of 25 case patients and of 79 control patients with neutropenic fever in the emergency department.

CharacteristicsTotal (n = 104)Case (n = 25)Control (n = 79)P value

Vital signs on presentation
 SBP, mm Hg119.1 ± 21.6106.7 ± 24.6122 (110-135)0.001∗∗
 DBP, mm Hg70.8 ± 14.362.0 ± 14.173.6 ± 13.30.0003∗∗∗
 PR, beats/min110 (92-128)119.7 ± 18.9106.0 (88.5-124.7)0.013
 RR, breaths/min18 (18-20)20 (18-24)18 (18-20)0.252
 Body temperature, °C38.4 (38-38.9)38.5 (38.0-38.1)38.3 (38.0-38.7)0.649
 Saturation, %97 (96-98)96.0 (93.1-97.0)97 (96-98)0.001∗∗

qSOFA0.49 ± 0.630.88 ± 0.780.36 ± 0.530.0003∗∗∗

Complete blood cell counts
 Leukocyte count, x109cells/mL1120(615-1570)710 (462-1473)1170 (702-1625)0.056
 ANC205 (84-567)174 (67-335)222 (101-666)0.087
 Profound neutropenia, no. (%)29 (28)10 (25)19 (24)0.123
 Hemoglobin, g/dL9.6 ± 2.18.1 ± 2.210.3 (9.1-11)< 0.0001∗∗∗
 Platelet, x103/μl95 (52-178)52 (27-114)123 (68-188)0.002∗∗

Other laboratory findings
 CRP, mg/dL5.5 (3-12.6)10.2 (6.5-17.7)4.0 (2.2-9.5)< 0.0001∗∗∗
 Lactic acid, mmol/L1.9 (1.4-2.5)2.15 (1.4-5.0)1.75 (1.4-2.35)0.126
 Glucose, mg/dL131 (112-161)159 ± 55.4129 (112-147)0.106
 Total bilirubin, mg/dL0.7 (0.5-1.1)0.9 (0.5-1.2)0.6 (0.4-0.9)0.029
 Creatinine, mg/dl0.77 (0.62-0.96)0.97 (0.74-2.01)0.72 (0.62-0.89)0.001∗∗
 Albumin, g/dL3.5 (3.2-3.8)3.1 ± 0.43.7 (3.3-3.8)0.0004∗∗∗

Arterial blood gas
 pH7.47 (7.44-7.49)7.46(7.43-7.49)7.47 ± 0.030.124
 PCO2, mm Hg31.5 ± 5.730.6 ± 8.131.9 ± 4.60.334
 PO2, mm Hg81.2 (73.7-94.8)78.7 (69.6-95.9)81.6 (78.8 -91.4)0.402
 HC, mmol/L22.7 (20.8-24.9)20.2 ± 4.823.4 ± 2.80.0002∗∗∗
 SpO2, mm Hg96.7 (95.3-97.7)96.2 (94-97.5)96.8 (95.5-97.7)0.150

<0.05, ∗∗p<0.01 ∗∗∗p<0.001: significant change from baseline values.
qSOFA: quick sepsis-related organ failure assessment; ANC: absolute neutrophil count; CRP: C-reactive protein.